Global Biosimilars Market is estimated to be worth close to $18 billion in 2020 and is projected to expand at a Double-Digit Rate
A biosimilar is a biological product that is similar to a reference biologic in terms of potency, purity, and safety, with no clinically significant changes.
Global Biosimilars Market is estimated close to $18 Bn (2020) growing at a double-digit rate. The market growth is driven by increasing number of biosimilar approvals and growing number of biologics going off-patent.
Loss of...
0 Commentaires
0 parts